ConductScience.org, home

Paper51188

Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients.

Desmyter J and 4 others. Lancet, 1975. Cited by 54 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients. Papers, record 51188. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/51188

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients.
PubMed
Journal
Lancet
PubMed
Year
1975
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
2.9
iCite
Revised in PubMed
2015-06-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Desmyter JJ
2Bradburne AFA F
3Vermylen CC
4Daneels RR
5Boelaert JJ

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
Hepatitis BMajor topic
Hepatitis B AntibodiesMajor topic
Hepatitis B AntigensMajor topic
ImmunoglobulinsMajor topic
Renal DialysisMajor topic
Adult
Antibodies, Viral
Clinical Trials as Topic
Hepatitis B virus
Humans
Time Factors

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
6,811,086Use of immunoglobulin with high content of antibody to hepatitis B surface antigen (anti-HBs). Working Party on the Clinical Use of Specific Immunoglobulin in Hepatitis B.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6811086PubMed
6,267,318Hepatocellular carcinoma- etiologic considerations: a review of the literature.J Natl Med Assoc1981https://conductscience.org/library/papers/6267318PubMed
1,276,774Hepatitis B in retreat from dialysis units in United Kingdom in 1973. Public Health Laboratory Service Survey.Br Med J1976https://conductscience.org/library/papers/1276774PubMed
1,081,418Editorial: After type B hepatitis.Br Med J1975https://conductscience.org/library/papers/1081418PubMed
822,594Viral hepatitis, type B.Yale J Biol Med1976https://conductscience.org/library/papers/822594PubMed
341,538Antiviral therapy.Yale J Biol Med1977https://conductscience.org/library/papers/341538PubMed
196,274Recent advances in the identification of hepatitis viruses.Postgrad Med J1977https://conductscience.org/library/papers/196274PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/51188

GET https://conductscience.org/api/papers/v1/51188/authors